TapImmune Inc

United States · 2 Employees
TapImmune is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a powerful standalone therapy or part of a leading combination regimen by complementing other approved or development-stage immunotherapeutics (i.e. checkpoint inhibitors). The company's off-the-shelf vaccines boost patients' immune systems to comprehensively stimulate both killer T-cells and helper T-cells to destroy cancer cells, and they are designed to work with 80% of the population. TapImmune is advancing two clinical stage T-cell vaccine candidates in multiple Phase II and Phase Ib/IIa clinical trials for treating ovarian and breast cancers, including programs in ovarian cancer that will benefit from FDA Fast Track and Orphan Disease Designation. The company is working in collaboration with industry and clinical leaders including Mayo Clinic, Memorial Sloan Kettering Cancer Center, and AstraZeneca.

概述

国家 United States
成立时间 2007
总部 5 West Forsyth St., Suite 200, Jacksonville, FL 32202, US
电话号码 +1 713-400-6400
网站 http://www.tapimmune.com
LinkedIn http://www.linkedin.com/company/tapimmune-inc
Twitter http://www.twitter.com/TapImmuneInc
Facebook https://facebook.com/tap.immune/
员工数 2
行业 research,
简介 TapImmune is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a powerful standalone therapy or part of a leading combination regimen by complementing other approved or development-stage immunotherapeutics (i.e. checkpoint inhibitors). The company's off-the-shelf vaccines boost patients' immune systems to comprehensively stimulate both killer T-cells and helper T-cells to destroy cancer cells, and they are designed to work with 80% of the population. TapImmune is advancing two clinical stage T-cell vaccine candidates in multiple Phase II and Phase Ib/IIa clinical trials for treating ovarian and breast cancers, including programs in ovarian cancer that will benefit from FDA Fast Track and Orphan Disease Designation. The company is working in collaboration with industry and clinical leaders including Mayo Clinic, Memorial Sloan Kettering Cancer Center, and AstraZeneca.

技术

Outlook

Email Providers

常见问题

TapImmune Inc 在哪里?

TapImmune Inc 的总部位于 5 West Forsyth St., Suite 200, Jacksonville, FL 32202, US

TapImmune Inc 的电话号码是多少?

TapImmune Inc 的电话号码是 +1 713-400-6400

TapImmune Inc 的官方网站是什么?

TapImmune Inc 的公司官方网站是 http://www.tapimmune.com

TapImmune Inc 是做什么的?

TapImmune Inc 的业务有哪些?

biotechnology,life sciences,immunotherapy,vaccines,oncology,infectious diseases

TapImmune Inc 的年收入是多少?

TapImmune Inc 的收入是 206000000美元

TapImmune Inc 有多少员工?

TapImmune Inc 有 2 名员工

TapImmune Inc 属于哪个行业?

TapImmune Inc 从事以下行业: research

TapImmune Inc 使用什么技术?

TapImmune Inc 使用的一些流行技术包括: Outlook

如何联系 TapImmune Inc?

TapImmune Inc 联系信息: 电话号码:+1 713-400-6400， 网站:http://www.tapimmune.com， 邮箱：rmc***@***.com

TapImmune Inc 的社交媒体链接是什么?

TapImmune Inc 领英：http://www.linkedin.com/company/tapimmune-inc,fackbook：https://facebook.com/tap.immune/,twitte:http://www.twitter.com/TapImmuneInc

TapImmune Inc 是一家上市公司吗?

是的,TapImmune Inc是一家上市公司,在nasdaq公开挂牌上市，上市交易代码：TPIV

TapImmune Inc 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 TapImmune Inc?

TapImmune Inc 有 0 家投资者,包括 。

管理层

Robin McCallum

Project Director, CMC

员工

外贸获客 查找关键决策人

10亿+海关交易数据，1.2亿企业数据，2亿+企业联系人数据，1000千万真实采购商。覆盖200+个国家及地区，95%外贸重点拓展市场，可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少，成就更大，销售更聪明

查找更多 B2B 联系人，丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google